The objective of this study by Jo, et al.
A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.
A study led by a University of Manitoba researcher has brought science one step closer to using the chickenpox virus to develop a vaccine against HIV.
Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019
Artemisinin is derived from the leaves and flowers of the annual mugwort (Artemisia annua) and has been used in traditional Chinese medicine for centuries. The effectiveness was investigated by the Chinese researcher Tu Youyou. Her research was 2015 rewarded with the Nobel Prize.
Vanderbilt vaccine researchers are enrolling adult volunteers in a National Institutes of Health (NIH)-sponsored Phase II clinical trial that will study a next-generation pertussis vaccine that may protect people from whooping cough.
The Food and Drug Administration (FDA) announces it has permitted marketing of a new test to aid in the diagnosis of a sexually-transmitted infection (STI) called Mycoplasma genitalium (M. gen.). This is the first test authorized by the FDA to test for the M. gen.
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children’s Hospital Medical Center.
Contaminated Mobile Technology: Making it Part of Your Institution's Cleaning and Disinfection Program
By Kelly M. Pyrek
Researchers at Liverpool School of Tropical Medicine (LSTM) and Imperial College London have designed drugs which could help combat any potential new flu pandemic, by targeting the receptors of the cells by which the virus gains entry to the human body.